Genetic testing for Alzheimer's and long-term care insurance

Donald H. Taylor, Robert Cook-Deegan, Susan Hiraki, J. Scott Roberts, Dan G. Blazer, Robert C. Green

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced into the insurance market, coverage rates could be affected in different ways, depending on who possesses that information. Policymakers will eventually need to confront the issue of the use of this and other markers in the pricing of long-term care insurance.

Original languageEnglish (US)
Pages (from-to)102-108
Number of pages7
JournalHealth Affairs
Volume29
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Long-Term Care Insurance
Genetic Testing
Alzheimer Disease
Insurance Coverage
Long-Term Care
Apolipoproteins E
Genetic Markers
Costs and Cost Analysis

ASJC Scopus subject areas

  • Health Policy

Cite this

Taylor, D. H., Cook-Deegan, R., Hiraki, S., Roberts, J. S., Blazer, D. G., & Green, R. C. (2010). Genetic testing for Alzheimer's and long-term care insurance. Health Affairs, 29(1), 102-108. https://doi.org/10.1377/hlthaff.2009.0525

Genetic testing for Alzheimer's and long-term care insurance. / Taylor, Donald H.; Cook-Deegan, Robert; Hiraki, Susan; Roberts, J. Scott; Blazer, Dan G.; Green, Robert C.

In: Health Affairs, Vol. 29, No. 1, 01.2010, p. 102-108.

Research output: Contribution to journalArticle

Taylor, DH, Cook-Deegan, R, Hiraki, S, Roberts, JS, Blazer, DG & Green, RC 2010, 'Genetic testing for Alzheimer's and long-term care insurance', Health Affairs, vol. 29, no. 1, pp. 102-108. https://doi.org/10.1377/hlthaff.2009.0525
Taylor, Donald H. ; Cook-Deegan, Robert ; Hiraki, Susan ; Roberts, J. Scott ; Blazer, Dan G. ; Green, Robert C. / Genetic testing for Alzheimer's and long-term care insurance. In: Health Affairs. 2010 ; Vol. 29, No. 1. pp. 102-108.
@article{05325a7c78cc43a2a20afbfd600367cf,
title = "Genetic testing for Alzheimer's and long-term care insurance",
abstract = "A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced into the insurance market, coverage rates could be affected in different ways, depending on who possesses that information. Policymakers will eventually need to confront the issue of the use of this and other markers in the pricing of long-term care insurance.",
author = "Taylor, {Donald H.} and Robert Cook-Deegan and Susan Hiraki and Roberts, {J. Scott} and Blazer, {Dan G.} and Green, {Robert C.}",
year = "2010",
month = "1",
doi = "10.1377/hlthaff.2009.0525",
language = "English (US)",
volume = "29",
pages = "102--108",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project Hope",
number = "1",

}

TY - JOUR

T1 - Genetic testing for Alzheimer's and long-term care insurance

AU - Taylor, Donald H.

AU - Cook-Deegan, Robert

AU - Hiraki, Susan

AU - Roberts, J. Scott

AU - Blazer, Dan G.

AU - Green, Robert C.

PY - 2010/1

Y1 - 2010/1

N2 - A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced into the insurance market, coverage rates could be affected in different ways, depending on who possesses that information. Policymakers will eventually need to confront the issue of the use of this and other markers in the pricing of long-term care insurance.

AB - A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced into the insurance market, coverage rates could be affected in different ways, depending on who possesses that information. Policymakers will eventually need to confront the issue of the use of this and other markers in the pricing of long-term care insurance.

UR - http://www.scopus.com/inward/record.url?scp=77957366360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957366360&partnerID=8YFLogxK

U2 - 10.1377/hlthaff.2009.0525

DO - 10.1377/hlthaff.2009.0525

M3 - Article

VL - 29

SP - 102

EP - 108

JO - Health Affairs

JF - Health Affairs

SN - 0278-2715

IS - 1

ER -